Pfizer Joins Russia Land Rush, But Chooses To Partner Rather Than Build

WASHINGTON - In the latest announcement from Big Pharma about going local in Russia, Pfizer Inc. said June 29 that it had signed a memorandum of understanding with ChemRar High Tech Center, a Moscow incubator, to explore a collaboration focused on research, development and commercialization of innovative drugs in Russia and other countries